Sunil Kumar Yadava
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sunil Kumar Yadava has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Jyotsnendu Giri
Engineering Nanomaterials and Regenerative Medicine Lab, Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi, Telangana, 502284, India
5 shared publications Ruby Singh
Department of Biomedical Engineering, Indian Institute of Technology, Hyderabad, India
4 shared publicationsSuparna Mercy Basu
Department of Biomedical Engineering, Indian Institute of Technology, Hyderabad, India
4 shared publications- Arpan Pradhan
Emory National Primate Research Center and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA
3 shared publications Jayesh S. Patil
Department of Pharmaceutical Technology, University Institute of Chemical Technology, North Maharashtra University, Jalgaon, India
3 shared publicationsJayesh Patil
2 shared publications
Latest Publications
- Open Access
- 20 March 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (13) , 15981-15992
Hybrid Lipid Nanocapsules: A Robust Platform for mRNA Delivery
The success of the mRNA vaccine against COVID-19 has garnered significant interest in the development of mRNA therapeutics against other diseases, but there remains a strong need for a stable and versatile delivery platform for these therapeutics. In this study, we report on a family of robust hybrid lipid nanocapsules (hLNCs) for the delivery of mRNA. The hLNCs are composed of kolliphore HS15, labrafac lipophile WL1349, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), and a conjugate of oleic acid (OA) and polyethylenimines of varying size (PEI─0.8, 1.8, and 25 kDa). They are prepared by a solvent-free, temperature-phase inversion method, yielding an average size of ∼40 nm and a particle distribution index (PDI) < 0.2. We demonstrate that the PDI remains <0.2 over a wide pH range and in a wide range of medium. We further show that the PDI and the functionality of mRNA condensed on the particles are robust to drying in a sugar glass and subsequent rehydration. Finally, we demonstrate that mRNA-loaded hLNCs yield reasonable transfection in vitro and in vivo settings.
- 20 March 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (13) , 15981-15992
Open AccessHybrid Lipid Nanocapsules: A Robust Platform for mRNA Delivery
The success of the mRNA vaccine against COVID-19 has garnered significant interest in the development of mRNA therapeutics against other diseases, but there remains a strong need for a stable and versatile delivery platform for these therapeutics. In this study, we report on a family of robust hybrid lipid nanocapsules (hLNCs) for the delivery of mRNA. The hLNCs are composed of kolliphore HS15, labrafac lipophile WL1349, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), and a conjugate of oleic acid (OA) and polyethylenimines of varying size (PEI─0.8, 1.8, and 25 kDa). They are prepared by a solvent-free, temperature-phase inversion method, yielding an average size of ∼40 nm and a particle distribution index (PDI) < 0.2. We demonstrate that the PDI remains <0.2 over a wide pH range and in a wide range of medium. We further show that the PDI and the functionality of mRNA condensed on the particles are robust to drying in a sugar glass and subsequent rehydration. Finally, we demonstrate that mRNA-loaded hLNCs yield reasonable transfection in vitro and in vivo settings.
- 1 August 2021
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 204, 111775
Lipid nanocapsules co-encapsulating paclitaxel and salinomycin for eradicating breast cancer and cancer stem cells
- 1 August 2021
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 204, 111775
Lipid nanocapsules co-encapsulating paclitaxel and salinomycin for eradicating breast cancer and cancer stem cells
- 27 September 2020
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 3 (10) , 6811-6822
Curcumin-Loaded Nanostructure Hybrid Lipid Capsules for Co-eradication of Breast Cancer and Cancer Stem Cells with Enhanced Anticancer Efficacy
Co-eradication of cancer stem cells (CSCs) along with cancer cells has emerged as an immediate necessity to combat the rapid progression, therapeutic resistance and relapse of cancer. Curcumin (CMN) has been well-established for anticancer activity against variety of cancers with an ability to eliminate CSCs. In spite of its extensive therapeutic potential, the clinical applicability is impeded due to its highly hydrophobic nature. In this study we developed CMN loaded hybrid lipid nanocapsules (CMN-nHLCs) of three sizes (25, 75 and 150 nm) with 4% (w/w) loading capacity using our low temperature (LT) method. Molecular interaction between different ingredients using FTIR analysis shows self-arrangement of ingredients into CMN loaded nHLCs without any chemical bonding. CMN-nHLCs show controlled release of CMN from nHLCs at 37 °C and long term storage stability at 4 oC. CMN-nHLCs show ~2.5 fold enhanced anticancer efficacy compared to free CMN in breast cancer cells (non-bCSCs) and breast cancer stem like cells (bCSCs). CMN-nHLCs are effectively internalized into MCF-7 cells (non-bCSCs and bCSCs), and cause significant reduction in their mammosphere size/number and stemness. nHLCs provide improved physicochemical properties of CMN, and superior anticancer efficacy by co-eradiating both non-bCSCs and bCSCs, suggesting a promising candidature of CMN-nHLCs for breast cancer treatment.
- 27 September 2020
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 3 (10) , 6811-6822
Curcumin-Loaded Nanostructure Hybrid Lipid Capsules for Co-eradication of Breast Cancer and Cancer Stem Cells with Enhanced Anticancer Efficacy
Co-eradication of cancer stem cells (CSCs) along with cancer cells has emerged as an immediate necessity to combat the rapid progression, therapeutic resistance and relapse of cancer. Curcumin (CMN) has been well-established for anticancer activity against variety of cancers with an ability to eliminate CSCs. In spite of its extensive therapeutic potential, the clinical applicability is impeded due to its highly hydrophobic nature. In this study we developed CMN loaded hybrid lipid nanocapsules (CMN-nHLCs) of three sizes (25, 75 and 150 nm) with 4% (w/w) loading capacity using our low temperature (LT) method. Molecular interaction between different ingredients using FTIR analysis shows self-arrangement of ingredients into CMN loaded nHLCs without any chemical bonding. CMN-nHLCs show controlled release of CMN from nHLCs at 37 °C and long term storage stability at 4 oC. CMN-nHLCs show ~2.5 fold enhanced anticancer efficacy compared to free CMN in breast cancer cells (non-bCSCs) and breast cancer stem like cells (bCSCs). CMN-nHLCs are effectively internalized into MCF-7 cells (non-bCSCs and bCSCs), and cause significant reduction in their mammosphere size/number and stemness. nHLCs provide improved physicochemical properties of CMN, and superior anticancer efficacy by co-eradiating both non-bCSCs and bCSCs, suggesting a promising candidature of CMN-nHLCs for breast cancer treatment.
- 1 June 2020
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 190, 110927
Low temperature, easy scaling up method for development of smart nanostructure hybrid lipid capsules for drug delivery application
- 1 June 2020
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 190, 110927
Low temperature, easy scaling up method for development of smart nanostructure hybrid lipid capsules for drug delivery application
- Open Access
- 6 January 2020
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 18 (1) , 1-19
Biological response and cytotoxicity induced by lipid nanocapsules
Background: Lipid nanocapsules (LNCs) are promising vehicles for drug delivery. However, since not much was known about cellular toxicity of these nanoparticles in themselves, we have here investigated the mechanisms involved in LNC-induced intoxication of the three breast cancer cell lines MCF-7, MDA-MD-231 and MDA-MB-468. The LNCs used were made of Labrafac™ Lipophile WL1349, Lipoid®S75 and Solutol®HS15.Results: High resolution SIM microscopy showed that the DiD-labeled LNCs ended up in lysosomes close to the membrane. Empty LNCs, i.e. without encapsulated drug, induced not only increased lysosomal pH, but also acidification of the cytosol and a rapid inhibition of protein synthesis. The cytotoxicity of the LNCs were measured for up to 72 h of incubation using the MTT assay and ATP measurements in all three cell lines, and revealed that MDA-MB-468 was the most sensitive cell line and MCF-7 the least sensitive cell line to these LNCs. The LNCs induced generation of reactive free oxygen species and lipid peroxidation. Experiments with knock-down of kinases in the near-haploid cell line HAP1 indicated that the kinase HRI is essential for the observed phosphorylation of eIF2α. Nrf2 and ATF4 seem to play a protective role against the LNCs in MDA-MB-231 cells, as knock-down of these factors sensitizes the cells to the LNCs. This is in contrast to MCF-7 cells where the knock-down of these factors had a minor effect on the toxicity of the LNCs. Inhibitors of ferroptosis provided a large protection against LNC toxicity in MDA-MB-231 cells, but not in MCF-7 cells.Conclusions: High doses of LNCs showed a different degree of toxicity on the three cell lines studied, i.e. MCF-7, MDA-MD-231 and MDA-MB-468 and affected signaling factors and the cell fate differently in these cell lines.
- 6 January 2020
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 18 (1) , 1-19
Open AccessBiological response and cytotoxicity induced by lipid nanocapsules
Background: Lipid nanocapsules (LNCs) are promising vehicles for drug delivery. However, since not much was known about cellular toxicity of these nanoparticles in themselves, we have here investigated the mechanisms involved in LNC-induced intoxication of the three breast cancer cell lines MCF-7, MDA-MD-231 and MDA-MB-468. The LNCs used were made of Labrafac™ Lipophile WL1349, Lipoid®S75 and Solutol®HS15.Results: High resolution SIM microscopy showed that the DiD-labeled LNCs ended up in lysosomes close to the membrane. Empty LNCs, i.e. without encapsulated drug, induced not only increased lysosomal pH, but also acidification of the cytosol and a rapid inhibition of protein synthesis. The cytotoxicity of the LNCs were measured for up to 72 h of incubation using the MTT assay and ATP measurements in all three cell lines, and revealed that MDA-MB-468 was the most sensitive cell line and MCF-7 the least sensitive cell line to these LNCs. The LNCs induced generation of reactive free oxygen species and lipid peroxidation. Experiments with knock-down of kinases in the near-haploid cell line HAP1 indicated that the kinase HRI is essential for the observed phosphorylation of eIF2α. Nrf2 and ATF4 seem to play a protective role against the LNCs in MDA-MB-231 cells, as knock-down of these factors sensitizes the cells to the LNCs. This is in contrast to MCF-7 cells where the knock-down of these factors had a minor effect on the toxicity of the LNCs. Inhibitors of ferroptosis provided a large protection against LNC toxicity in MDA-MB-231 cells, but not in MCF-7 cells.Conclusions: High doses of LNCs showed a different degree of toxicity on the three cell lines studied, i.e. MCF-7, MDA-MD-231 and MDA-MB-468 and affected signaling factors and the cell fate differently in these cell lines.
- 3 December 2019
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 17 (1) , 284-300
Protein–Sugar-Glass Nanoparticle Platform for the Development of Sustained-Release Protein Depots by Overcoming Protein Delivery Challenges
Therapeutic protein depots have limited clinical success because of the presence of critical preparation barriers such as low encapsulation, uncontrolled release, and activity loss during processing and storage. In the present study, we used our novel protein-nanoencapsulation (into sugar-glass nanoparticle; SGnP) platform to prepare a protein depot to overcome the abovementioned formidable challenges. The SGnP-mediated microparticle protein depot has been validated using four model proteins (bovine serum albumin, horseradish peroxidase, fibroblastic growth factor, and epidermal growth factor) and model biodegradable poly(lactic-co-glycolic acid) polymer system. The results show that our protein-nanoencapsulation-mediated platform provides a new generic platform to prepare a protein depot through the conventional emulsion method of any polymer and single/multiple protein systems. This protein depot has the required pharmaceutical properties such as high encapsulation efficiency, burst-free sustained release, and protein preservation during processing and storage, making it suitable for off-the-shelf use in therapeutic protein delivery and tissue engineering applications.
- 3 December 2019
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 17 (1) , 284-300
Protein–Sugar-Glass Nanoparticle Platform for the Development of Sustained-Release Protein Depots by Overcoming Protein Delivery Challenges
Therapeutic protein depots have limited clinical success because of the presence of critical preparation barriers such as low encapsulation, uncontrolled release, and activity loss during processing and storage. In the present study, we used our novel protein-nanoencapsulation (into sugar-glass nanoparticle; SGnP) platform to prepare a protein depot to overcome the abovementioned formidable challenges. The SGnP-mediated microparticle protein depot has been validated using four model proteins (bovine serum albumin, horseradish peroxidase, fibroblastic growth factor, and epidermal growth factor) and model biodegradable poly(lactic-co-glycolic acid) polymer system. The results show that our protein-nanoencapsulation-mediated platform provides a new generic platform to prepare a protein depot through the conventional emulsion method of any polymer and single/multiple protein systems. This protein depot has the required pharmaceutical properties such as high encapsulation efficiency, burst-free sustained release, and protein preservation during processing and storage, making it suitable for off-the-shelf use in therapeutic protein delivery and tissue engineering applications.
- Open Access
- 29 January 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 915
Effect of Fluoride Doping in Laponite Nanoplatelets on Osteogenic Differentiation of Human Dental Follicle Stem Cells (hDFSCs)
Bioactive nanosilicates are emerging prominent next generation biomaterials due to their intrinsic functional properties such as advanced biochemical and biophysical cues. Recent studies show interesting dose-dependent effect of fluoride ions on the stem cells. Despite of interesting properties of fluoride ions as well as nanosilicate, there is no reported literature on the effect of fluoride-doped nanosilicates on stem cells. We have systematically evaluated the interaction of fluoride nanosilicate platelets (NS + F) with human dental follicle stem cells (hDFSCs) to probe the cytotoxicity, cellular transport (internalization) and osteogenic differentiation capabilities in comparison with already reported nanosilicate platelets without fluoride (NS − F). To understand the osteoinductive and osteoconductive properties of the nanosilicate system, nanosilicate treated hDFSCs are cultured in three different medium namely normal growth medium, osteoconductive medium, and osteoinductive medium up to 21 d. NS + F treated stem cells show higher ALP activity, osteopontin levels and significant alizarin red staining compared to NS − F treated cells. This study highlights that the particles having fluoride additives (NS + F) aid in enhancing the osteogenic differentiation capabilities of hDFSCs thus potential nanobiomaterial for periodontal bone tissue regeneration.
- 29 January 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 915
Open AccessEffect of Fluoride Doping in Laponite Nanoplatelets on Osteogenic Differentiation of Human Dental Follicle Stem Cells (hDFSCs)
Bioactive nanosilicates are emerging prominent next generation biomaterials due to their intrinsic functional properties such as advanced biochemical and biophysical cues. Recent studies show interesting dose-dependent effect of fluoride ions on the stem cells. Despite of interesting properties of fluoride ions as well as nanosilicate, there is no reported literature on the effect of fluoride-doped nanosilicates on stem cells. We have systematically evaluated the interaction of fluoride nanosilicate platelets (NS + F) with human dental follicle stem cells (hDFSCs) to probe the cytotoxicity, cellular transport (internalization) and osteogenic differentiation capabilities in comparison with already reported nanosilicate platelets without fluoride (NS − F). To understand the osteoinductive and osteoconductive properties of the nanosilicate system, nanosilicate treated hDFSCs are cultured in three different medium namely normal growth medium, osteoconductive medium, and osteoinductive medium up to 21 d. NS + F treated stem cells show higher ALP activity, osteopontin levels and significant alizarin red staining compared to NS − F treated cells. This study highlights that the particles having fluoride additives (NS + F) aid in enhancing the osteogenic differentiation capabilities of hDFSCs thus potential nanobiomaterial for periodontal bone tissue regeneration.
- 2 December 2016
- Published by Bentham Science Publishers Ltd. in Micro and Nanosystems
- Vol. 8 (1) , 31-40
Development of Encapsulated Self Healed Microparticles: Evaluation by RSM
- 2 December 2016
- Published by Bentham Science Publishers Ltd. in Micro and Nanosystems
- Vol. 8 (1) , 31-40
Development of Encapsulated Self Healed Microparticles: Evaluation by RSM
- 4 January 2016
- Published by Taylor & Francis in Drying Technology
- Vol. 34 (12) , 1455-1461
Formulation of metformin hydrochloride nanoparticles by using spray drying technique and in vitro evaluation of sustained release with 32-level factorial design approach
The aim of this study was to investigate the combined influence of two independent variables in the preparation of sustained release metformin hydrochloride (MH) nanoparticles by 32-factorial design using a spray drying method. Polymer concentration and amount of organic solvent are selected as independent variables while drug loading and drug release were considered as dependent variables. The nanoparticles were characterized using particle size analyzer, which is obtained in the range of 400–700 nm, Fourier transform infrared spectroscopy, and X-ray diffraction. The kinetics of the dissolution process was studied by analyzing the dissolution data. The results suggested that MH nanoparticles are suitable for sustained release of drug.
- 4 January 2016
- Published by Taylor & Francis in Drying Technology
- Vol. 34 (12) , 1455-1461
Formulation of metformin hydrochloride nanoparticles by using spray drying technique and in vitro evaluation of sustained release with 32-level factorial design approach
The aim of this study was to investigate the combined influence of two independent variables in the preparation of sustained release metformin hydrochloride (MH) nanoparticles by 32-factorial design using a spray drying method. Polymer concentration and amount of organic solvent are selected as independent variables while drug loading and drug release were considered as dependent variables. The nanoparticles were characterized using particle size analyzer, which is obtained in the range of 400–700 nm, Fourier transform infrared spectroscopy, and X-ray diffraction. The kinetics of the dissolution process was studied by analyzing the dissolution data. The results suggested that MH nanoparticles are suitable for sustained release of drug.